NCT01167062

Efficacy of Tamsulosin Oral-controlled Absorption System (OCAS) in the Treatment of Distal Ureteral Stones

Efficacy of Tamsulosin OCAS in the Conjunctive Medical Treatment of Distal Ureteral Stones.A Randomized, Double-blind, Placebo-controlled Study

• Status: Unknown
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 120 (estimated)
• Sponsor: Chiang Mai University · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This is a randomized double blind placebo-controlled study that will assess the efficacy of Tamsulosin oral-controlled absorption system (OCAS) 0.4 mg in the conjunctive medical treatment of distal ureteral stones with a size of 4-10 mm compared to placebo in control group.

Detailed description

* patient will be randomized to receive placebo or Tamsulosin OCAS 0.4 mg 1 tablet OD for a maximum of 28 days or until the ureteral stone is passed and sodium diclofenac 50 mg twice a day, for 10 days. * All patients will receive 75 mg sodium diclofenac via intramuscular on demand

Conditions

• Ureteral Calculi

Interventions

Type	Name	Description
DRUG	Tamsulosin Hydrochloride OCAS 0.4 mg	One tablet OD for a maximum of 28 days
OTHER	Placebo	One tablet OD for a maximum of 28 days

Timeline

• Start date: 2010-06-01
• Primary completion: 2011-04-01
• First posted: 2010-07-22
• Last updated: 2010-07-22

Locations

1 site across 1 country: Thailand